777056-79-8 Usage
Uses
Used in Organic Synthesis:
4-Pyridinemethanamine,2-fluoro-(9CI) is used as a building block in organic synthesis for the creation of more complex molecules. Its unique structure with a fluorine atom and an amine group allows for versatile chemical reactions and the formation of a variety of compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Pyridinemethanamine,2-fluoro-(9CI) is used as a research compound for the development of new drugs. Its properties may contribute to the discovery of novel therapeutic agents with potential applications in various medical fields.
Used in Drug Development:
4-Pyridinemethanamine,2-fluoro-(9CI) may also be utilized in the development of new drugs, given its potential as a building block for more complex molecules. Its presence in a compound could influence the pharmacological properties, making it a valuable component in the design of innovative medications.
Check Digit Verification of cas no
The CAS Registry Mumber 777056-79-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,7,0,5 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 777056-79:
(8*7)+(7*7)+(6*7)+(5*0)+(4*5)+(3*6)+(2*7)+(1*9)=208
208 % 10 = 8
So 777056-79-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H7FN2/c7-6-3-5(4-8)1-2-9-6/h1-3H,4,8H2
777056-79-8Relevant articles and documents
BICYCLIC COMPOUNDS
-
Paragraph 00639; 00640, (2020/06/01)
Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
PYRIDAZINONE DERIVATIVES AND USE THEREOF AS P2X7 RECEPTOR INHIBITORS
-
Page/Page column 138-140, (2009/06/27)
Novel pyridazinone compounds of formula (I), which inhibit the purinergic P2X7 receptor and are useful for prevention, therapy and improvement of inflammatory and immunological diseases.
COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE
-
Page/Page column 38-39; 110, (2010/02/13)
Combination of one or more CB2 modulators such as a compound of formula (I), (II) and (III); and one more PDE4 inhibitors are useful of treating conditions which are mediated by the activity of CB2 receptors or conditions which are mediated by PDE4, such
PYRIMIDINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS
-
Page/Page column 39, (2010/02/13)
The present invention relates to novel pyrimidine derivatives such as compounds of the formula (I) and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of the cannabinoid 2 receptor.
